NovoCure (NVCR) Inventory Average (2015 - 2026)

NovoCure has disclosed Inventory Average across 12 years of filings, most recently posting $42.3 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $42.3 million, up 13.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.3 million (up 13.43% YoY), and the FY2025 annual result was $38.1 million, up 4.04% from the prior year.
• Inventory Average came in at $42.3 million for Q1 2026 at NovoCure, up from $40.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $42.3 million in Q1 2026 to a low of $26.8 million in Q1 2022.
• The 5-year median for Inventory Average is $37.3 million (2025), against an average of $35.6 million.
• Across the five-year window, Inventory Average soared 33.45% in 2023 and dropped 7.44% in 2025, its largest moves.
• NovoCure's Inventory Average stood at $28.1 million in 2022, then jumped by 33.45% to $37.5 million in 2023, then decreased by 1.04% to $37.1 million in 2024, then advanced by 8.13% to $40.1 million in 2025, then climbed by 5.43% to $42.3 million in 2026.
• The last three Inventory Average figures came in at $42.3 million (Q1 2026), $40.1 million (Q4 2025), and $39.7 million (Q3 2025), per Business Quant data.